Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Weiskopf

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Transfusion|March 23, 2016
What is innovation?Richard B Weiskopf
Anesthesiology|July 22, 2015
Lack of Nephrotoxicity of Hydroxyethyl Starch 130/0.4 When Used in SurgeryRichard B Weiskopf
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 27, 2007
Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo NordiskRichard B Weiskopf,
Anesthesiology|October 27, 2006
If you prick us, do we not bleed?Richard B Weiskopf
Anesthesia and Analgesia|October 26, 2010
Emergency transfusion for acute severe anemia: a calculated riskRichard B Weiskopf
Anesthesia and Analgesia|July 22, 2014
The efficacy and safety of liquid stored blood and storage duration: a confused subject; are patients confused?Richard B Weiskopf
Anesthesiology|October 16, 2013
Equivalent efficacy of hydroxyethyl starch 130/0.4 and human serum albumin: if nothing is the same, is everything different? The importance of context in clinical trials and statisticsRichard B Weiskopf
Anesthesiology|August 25, 2010
Conflicts of interest in expert-authored practice parameters, standards, guidelines, recommendationsRichard B Weiskopf
Anesthesiology|August 10, 2002
Intraoperative use of recombinant activated coagulation factor vIIRichard B Weiskopf
Anesthesiology|December 25, 2009
Perioperative use of beta-adrenergic antagonists and anemia: known knowns, known unknowns, unknown unknowns; and Unknown KnownsRichard B Weiskopf
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Transfusion|March 23, 2016
What is innovation?Richard B Weiskopf
Anesthesiology|July 22, 2015
Lack of Nephrotoxicity of Hydroxyethyl Starch 130/0.4 When Used in SurgeryRichard B Weiskopf
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 27, 2007
Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo NordiskRichard B Weiskopf,
Anesthesiology|October 27, 2006
If you prick us, do we not bleed?Richard B Weiskopf
Anesthesia and Analgesia|October 26, 2010
Emergency transfusion for acute severe anemia: a calculated riskRichard B Weiskopf
Anesthesia and Analgesia|July 22, 2014
The efficacy and safety of liquid stored blood and storage duration: a confused subject; are patients confused?Richard B Weiskopf
Anesthesiology|October 16, 2013
Equivalent efficacy of hydroxyethyl starch 130/0.4 and human serum albumin: if nothing is the same, is everything different? The importance of context in clinical trials and statisticsRichard B Weiskopf
Anesthesiology|August 25, 2010
Conflicts of interest in expert-authored practice parameters, standards, guidelines, recommendationsRichard B Weiskopf
Anesthesiology|August 10, 2002
Intraoperative use of recombinant activated coagulation factor vIIRichard B Weiskopf
Anesthesiology|December 25, 2009
Perioperative use of beta-adrenergic antagonists and anemia: known knowns, known unknowns, unknown unknowns; and Unknown KnownsRichard B Weiskopf
Pageof 8